期刊
MOLECULAR PHARMACEUTICS
卷 20, 期 1, 页码 481-490出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.2c00737
关键词
nonlinear pharmacokinetics; iron chelation therapy; saturable renal reabsorption; saturable absorption; nanomedicine
This study evaluated the absorption, distribution, and elimination of deferoxamine nanoparticles (DFO-NPs) in rats and found their potential in improving safety and efficacy. Predictive pharmacokinetic models were developed to describe the pharmacokinetics of DFO-NPs, providing information for preclinical development and clinical translation. Additionally, a novel mechanism of subcutaneous absorption directly into the systemic circulation was identified, offering a new strategy for enhancing drug exposure of nanotherapeutics.
Deferoxamine (DFO) is an effective FDA-approved iron chelator. However, its use is considerably limited by off-target toxicities and an extremely cumbersome dose regimen with daily infusions. The recent development of a deferoxamine-based nanochelator (DFO-NP) with selective renal excretion has shown promise in ameliorating animal models of iron overload with a substantially improved safety profile. To further the preclinical development of this promising nanochelator and to inform on the feasibility of clinical development, it is necessary to fully characterize the dose and administration-route-dependent pharmacokinetics and to develop predictive pharmacokinetic (PK) models describing absorption and disposition. Herein, we have evaluated the absorption, distribution, and elimination of DFO-NPs after intravenous and subcutaneous (SC) injection at therapeutically relevant doses in Sprague Dawley rats. We also characterized compartment-based model structures and identified model-based parameters to quantitatively describe the PK of DFO-NPs. Our modeling efforts confirmed that disposition could be described using a three-compartment mamillary model with elimination and saturable reabsorption both occurring from the third compartment. We also determined that absorption was nonlinear and best described by parallel saturable and first-order processes. Finally, we characterized a novel pathway for saturable SC absorption of an ultrasmall organic nanoparticle directly into the systemic circulation, which offers a novel strategy for improving drug exposure for nanotherapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据